Comparison of recovery between allogenic Wharton Jelly derived Stem cells versus Platelet Rich Plasma in patients undergoing hip arthroplasty for fracture neck of femur– A Pilot Prospective Randomised Double-Blinded Study
Not Applicable
- Conditions
- Health Condition 1: M849- Disorder of continuity of bone, unspecified
- Registration Number
- CTRI/2024/05/067344
- Lead Sponsor
- RESEARCH SECTION ALL INDIA INSTITUTE OF MEDICAL SCIENCES
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
NA
Exclusion Criteria
NA
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Short Physical Performance Battery (sPPB) at week 26 after injection serves as the primary end- point for evaluating efficacy.Timepoint: The Short Physical Performance Battery (sPPB) at week 26 after injection serves as the primary end- point for evaluating efficacy.
- Secondary Outcome Measures
Name Time Method To compare Lower Extremities Measure (LEM) and assessment of abduction strength in all the three groups at the end of 26 weeks and 52 weeks and cause of mortality if any at the end of 1 year.Timepoint: 26 weeks and 52 weeks